Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw – The Economic Times
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw The Economic Times Read the full story…
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw The Economic Times Read the full story…
Indian Pharma Industry Looks Beyond the US to Expand Global Exports Chemical Industry Digest Read the…
ICICI Prudential Launches Nifty Pharma ETF: NFO, Dates And Key Details Dalal Street Investment Journal Read…
Pharma industry welcomes cancer drug price cap, flags need to balance affordability and sustainability Moneycontrol.com Read…
ICICI Prudential Mutual Fund launches ICICI Prudential Nifty Pharma ETF Investment Guru India Read the full…
GST Council permits pharma cos to claim ITC on free samples, goods destroyed upon expiry…
ICICI Prudential Mutual Fund Launches ICICI Prudential Nifty Pharma ETF TradingView Read the full story at…
India’s drugmakers bet on innovation after generics scale-up ET Chemicals Read the full story at source…
Steep margins allow room for malpractice: Pharmaceuticals secretary The Times of India Read the full story…
Beyond cost what will shape India’s pharma competitiveness? Express Pharma Read the full story at source…